Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/27/2001 | WO2001098357A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
12/27/2001 | WO2001098354A2 Human receptors |
12/27/2001 | WO2001098353A2 Secreted proteins |
12/27/2001 | WO2001098351A2 G-protein coupled receptors |
12/27/2001 | WO2001098343A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
12/27/2001 | WO2001098342A1 Novel compounds |
12/27/2001 | WO2001098338A2 Fluorescent proteins |
12/27/2001 | WO2001098334A2 Streptococcus antigens |
12/27/2001 | WO2001098333A2 Modification of hepatitis b core antigen |
12/27/2001 | WO2001098332A2 Secreted redox proteins |
12/27/2001 | WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
12/27/2001 | WO2001098323A2 G-protein coupled receptors |
12/27/2001 | WO2001098318A1 Haplotypes of the slc26a2 gene |
12/27/2001 | WO2001097846A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
12/27/2001 | WO2001097600A1 Somatic embryogenic regeneration of acacia mangium |
12/27/2001 | WO2001075087A8 Subtilisin variants |
12/27/2001 | WO2001068811A3 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
12/27/2001 | WO2001059088A3 Vector |
12/27/2001 | WO2001051608A3 Hybrid cells obtainable from antigen presenting cells |
12/27/2001 | WO2001050851A3 Storage of cells, tissues and organs in gel-based media |
12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
12/27/2001 | WO2001046700A3 Sodium channels as targets for amyloid beta |
12/27/2001 | WO2001046256A3 Vesicle trafficking proteins |
12/27/2001 | WO2001044438A3 Serological diagnostic method with rickettsia pulicis bacterium |
12/27/2001 | WO2001040443A3 Method for producing adherent animal cells |
12/27/2001 | WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
12/27/2001 | WO2001038490A3 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
12/27/2001 | WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof |
12/27/2001 | WO2001027258A3 High yield protein expression system and methods |
12/27/2001 | WO2001012800A8 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
12/27/2001 | US20010056581 Vectors and methods for the mutagenesis of mammalian genes |
12/27/2001 | US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6 |
12/27/2001 | US20010055809 Media containing pure perfluorocarbon that may be oxygenated |
12/27/2001 | US20010055808 Use of collagenase in the preparation of neural stem cell cultures |
12/27/2001 | US20010055807 Immunoisolation of a cell; least one cell is encapsulated with a coating having a polyelectrolyte charge opposite to the charge of the cell/poly-beta-N-acetylglucosamine species |
12/27/2001 | US20010055806 Continuous cell-sheet structure consisting of monolayer of primary hepatocytes and the method of forming the sheet |
12/27/2001 | US20010055805 Surgical process for removal of segments of liver; remove sample of tissue from animal, culture tissue, evaluate tissue |
12/27/2001 | US20010055804 Apparatus for propagation, diagnosis, evalation and analysis of potentially tumorous tissues; antitumor agents; anticarcinogenic agents |
12/27/2001 | US20010055795 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
12/27/2001 | US20010055791 Methods for enhancing the production of interferon in cell culture |
12/27/2001 | US20010055789 Nucleotide sequences for use in the generation of amidated peptides |
12/27/2001 | US20010055788 Recombinant bacterial phytases and uses thereof |
12/27/2001 | US20010055758 Reagents and methods useful for detecting diseases of the prostate |
12/27/2001 | US20010055755 Dendritic marker-expressing macrophage cultures and methods for reactivating latent HCMV |
12/27/2001 | US20010055745 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells |
12/27/2001 | US20010055626 Apparatus and process for in situ manufacture of essence from living, uncut plants |
12/27/2001 | US20010055621 System for the production of autologous platelet gel |
12/27/2001 | US20010055590 Method for enhancing myoblast migration and invasion in the context of gene therapy |
12/27/2001 | US20010055588 Mixing a biodegradable, biocompatible hydrogel solution such as calcium alginate with dissociated cells and implanting the mixture into the animal; gels provide three-dimensional scaffolds |
12/27/2001 | US20010055587 Transplantation of neural cells for the treatment of chronic pain or spasticity |
12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
12/27/2001 | US20010055584 Improved nucleic acids encoding a chimeric glycosyltransferase |
12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
12/27/2001 | CA2414102A1 Universal collection medium |
12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
12/27/2001 | CA2414015A1 Human receptors |
12/27/2001 | CA2414010A1 Secreted redox proteins |
12/27/2001 | CA2414005A1 Novel compounds |
12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
12/27/2001 | CA2413801A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
12/27/2001 | CA2413526A1 Micro-organisms active in the digestive environment |
12/27/2001 | CA2413512A1 Cost effective media for large scale insect cell culture |
12/27/2001 | CA2413502A1 Tumour-cell specific gene expression and its use in cancer therapy |
12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
12/27/2001 | CA2413454A1 A g-protein coupled receptor |
12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
12/27/2001 | CA2413450A1 Streptococcus antigens |
12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
12/27/2001 | CA2413324A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
12/27/2001 | CA2412942A1 Nucleic acid sequences and methods for the modification of plant gene expression |
12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
12/27/2001 | CA2412484A1 G-protein coupled receptors |
12/27/2001 | CA2412110A1 Osteolevin gene polymorphisms |
12/27/2001 | CA2412053A1 Grain processing method and transgenic plants useful therein |
12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
12/27/2001 | CA2411971A1 Proteases |
12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
12/27/2001 | CA2409781A1 Phosphodiesterases |
12/27/2001 | CA2409778A1 Secreted proteins |
12/27/2001 | CA2409776A1 G-protein coupled receptors |
12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
12/27/2001 | CA2407788A1 Method for activating peroxisome proliferator activated receptor-.gamma. |
12/27/2001 | CA2379481A1 Somatic embryogenic regeneration of acacia mangium |
12/26/2001 | CN1328605A Methods for making recombinant cells |
12/26/2001 | CN1328571A Human monoclonal antibodies to CTLA-4 |
12/26/2001 | CN1328415A Plant fatty acid desaturase promoters |
12/26/2001 | CN1328131A Cell strain of high-transfer bladder cancer and its creating process |
12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
12/25/2001 | US6333450 Methods of selecting plants having delayed or inhibited ripening or senescence |
12/25/2001 | US6333449 Glufosinate tolerant rice |
12/25/2001 | US6333404 Human nucleosome assembly protein gene |
12/25/2001 | US6333318 Used in therapy; for delivering recombinant proteins into a variety of cells within a patient |
12/25/2001 | US6333310 NGF variants |
12/25/2001 | US6333193 Aggregation propagation catalyst; for use in culturing of cells |
12/25/2001 | US6333192 Generating culture of bird cells; recover bird gonadal cells, deposit cells in feeder matrix, propagate cells and monitor phenotypes |
12/25/2001 | US6333186 Modified forms of Hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease: inhibitor complexes |